Soluble interleukin-2 receptor, interleukin-2 and interleukin-4 in sera and supernatants from patients with progressive systemic sclerosis
Data up to Jan 2025
Total Citations Per Year
Abstract
References (39)
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
1980 • 4,703 citations
A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.
1981 • 1,366 citations
Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.
1985 • 1,143 citations
Expression of interleukin 2 receptors on activated human B cells.
1984 • 488 citations
Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE).
1983 • 453 citations
Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus.
1982 • 421 citations
Lymphocytes in the skin of patients with progressive systemic sclerosis
1984 • 369 citations
The released interleukin 2 receptor binds interleukin 2 efficiently.
1986 • 348 citations
Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells.
1985 • 288 citations
Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition.
1988 • 274 citations
Effect of tumor necrosis factor alpha on mitogen-activated human B cells.
1987 • 245 citations
Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus.
1988 • 162 citations
An analysis of the cellular requirements for the production of soluble interleukin-2 receptorsin vitro
1986 • 161 citations
Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus
1984 • 159 citations
Lymphotoxin Is an Important T Cell-Derived Growth Factor for Human B Cells
1987 • 151 citations
Interleukin-2 in Scleroderma: Correlation of Serum Level with Extent of Skin Involvement and Disease Duration
1989 • 134 citations
Soluble interleukin 2 receptor molecules in the serum of patients with autoimmune diseases
1989 • 121 citations
Silicone and rheumatic diseases
1987 • 112 citations
A syndrome resembling progressive systemic sclerosis after bone marrow transplantation
1979 • 105 citations
Lymphokine regulation of inflammatory processes: Interleukin-4 stimulates fibroblast proliferation
1988 • 98 citations
Purification of human B cell growth factor.
1985 • 95 citations
Production of B cell-stimulating factors by B cells in patients with systemic lupus erythematosus.
1988 • 92 citations
Interstitial lung disease in scleroderma analysis by bronchoalveolar lavage
1984 • 90 citations
Increased serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and rheumatoid arthritis
1988 • 89 citations
Purification to homogeneity of a high molecular weight human B cell growth factor; demonstration of specific binding to activated B cells; and development of a monoclonal antibody to the factor.
1985 • 88 citations
Scleroderma
1983 • 74 citations
Deficient interleukin 2 production in rheumatoid arthritis: association with active disease and systemic complications.
1988 • 63 citations
Polyclonal B lymphocyte activation in progressive systemic sclerosis.
1989 • 55 citations
Cellular immunity to collagen and laminin in scleroderma
1985 • 52 citations
Enhanced production of interleukin‐2 in patients with progressive systemic sclerosis. hyperactivity of cd4‐positive t cells?
1988 • 51 citations
Phenotype of peripheral blood lymphocytes in patients with progressive systemic sclerosis: activated T lymphocytes and the effect of D-penicillamine therapy.
1987 • 50 citations
Elevated titers of cell-free interleukin 2 receptor in serum of lupus mice.
1987 • 47 citations
Regulation of interleukin-2 receptor expression and receptor release
1986 • 43 citations
Noncytotoxic functions of natural killer (NK) cells: large granular lymphocytes (LGL) produce a B cell growth factor (BCGF).
1985 • 40 citations
Differences in the production of and/or the response to interleukin-2 by T lymphocytes from patients with the various connective tissue diseases
1984 • 38 citations
Natural killer activity and antibody-dependent cellular cytotoxicity in progressive systemic sclerosis
1990 • 21 citations
Activation,Proliferation and Differentiation of Human B Lymphocytes
1985 • 18 citations
Mononuclear cell-fibroblast interactions in scleroderma
1988 • 16 citations
Deleted Work
1955 • 0 citations